Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Frailty × cabozantinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 34 Carcinoma, Hepatocellular 16 Neoplasm Metastasis 13 Prostatic Neoplasms 12 Neoplasms 8 Neuroendocrine Tumors 6 Carcinoma, Non-Small-Cell Lung 6 Brain Neoplasms 6 Kidney Neoplasms 5 Breast Neoplasms 5 Sarcoma, Ewing 4 Sarcoma 4 Recurrence 4 Pancreatic Neoplasms 4 Osteosarcoma 4 Multiple Myeloma 4 Clear-cell metastatic renal cell carcinoma 4 Carcinoma, Transitional Cell 4 Urinary Bladder Neoplasms 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Thyroid Diseases 2 Neurofibroma, Plexiform 2 Melanoma 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Glioblastoma 2

Interventions

Geriatric Assessment 9 Preoperative Exercise 3 Standard of Care 2 Observation 2 Nutritional Support 2 Exercise 2 peflavit 1 microcrystalline cellulose 1 fisetin 1 epigallocatechin gallate 1 diacetamate 1 cabozantinib 1 Ultrasonography 1 Tretinoin 1 Therapeutics 1 Temozolomide 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Spectroscopy, Near-Infrared 1 Restraint, Physical 1 Quercetin 1 Qigong 1 Psychosocial Intervention 1 Protons 1 Photons 1 Nutrition Assessment 1 Methods 1 Immunonutrition Diet 1 Flavonoids 1 Enhanced Recovery After Surgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04134390 2024-01-09

CABOMAYOR

Spanish Oncology Genito-Urinary Group

Phase 2 Completed

Frailty, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡